Zhejiang Hailiang (002203.SZ) plans to launch an employee stock ownership plan in 2026, with an expected size not exceeding 80,636,100 shares.
Haoliang Group (002203.SZ) disclosed the Employee Stock Ownership Plan (draft) for the year 2026. The total number of employees participating in the 2026 Employee Stock Ownership Plan shall not exceed 300, including 8 directors and senior executives. After approval by the company's shareholders' meeting, the Employee Stock Ownership Plan will acquire and hold the company's repurchased shares through legal means such as non-trading transfers, totaling no more than 80.6361 million shares, accounting for 3.52% of the total current equity of the company. The Employee Stock Ownership Plan will acquire the company's repurchased shares from the company's repurchase account at a price of 9.00 yuan per share.
Zhejiang Hailiang (002203.SZ) disclosed the 2026 employee stock ownership plan (draft), with a total of not more than 300 employees participating, including 8 directors and senior management. After approval by the company's shareholders' meeting, the employee stock ownership plan will acquire and hold the company's shares held by the company's repurchase special securities account through non-trading transfer and other legal and regulatory means, totaling no more than 80,636,100 shares, accounting for 3.52% of the current total share capital of the company. The employee stock ownership plan will acquire the company's shares held by the company's repurchase special securities account at a transfer price of 9.00 yuan per share.
The term of the employee stock ownership plan is 120 months, starting from the date of transfer of the last target stock announced by the company to the employee stock ownership plan.
Related Articles

Yantai Zhenghai Bio-Tech (300653.SZ) has obtained a medical device registration certificate.

HK Stock Market Move | CHUANGXIN IND(02788) increased by more than 7% in the afternoon, the substitution of aluminum for copper is expected to accelerate, the company is expanding its electrolytic aluminum production capacity in Saudi Arabia.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.
Yantai Zhenghai Bio-Tech (300653.SZ) has obtained a medical device registration certificate.

HK Stock Market Move | CHUANGXIN IND(02788) increased by more than 7% in the afternoon, the substitution of aluminum for copper is expected to accelerate, the company is expanding its electrolytic aluminum production capacity in Saudi Arabia.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.

RECOMMEND

Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026

Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026

Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026


